Debanjan Pain, MD, MSCE
Department of Health Services Research, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2024 | University of Pennsylvania, Philadelphia, Pennsylvania, US, Clinical Epidemiology, MS |
| 2018 | Johns Hopkins School of Medicine, Baltimore, Maryland, US, Medicine, MD |
| 2013 | Harvard University, Cambridge, Massachusetts, US, Government, Health Policy, AB |
Postgraduate Training
| 2021-2024 | Fellowship, Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania |
| 2019-2021 | Residency, Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts |
| 2018-2019 | Internship, Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts |
Licenses & Certifications
| 2024 | Medical Oncology |
| 2021 | Internal Medicine |
Experience & Service
Intramural Institutional Committee Activities
Member, CPRTP NCI Summer Research Experience Selection Committee, The University of Texas at MD Anderson, 2025 - Present
Honors & Awards
| 2025 | Career Development Award, Robert A. Winn Excellence in Clinical Trials Program |
| 2025 | Early Clinical Investigator Award, Cancer Prevention & Research Institute of Texas |
| 2024 | BioOncology Award in Racial/Ethnic Disparities Research, Genentech |
| 2024 | New Investigator Recognition, American Society of Preventive Oncology |
| 2024 | Young Investigator Award, American Society of Clinical Oncology |
| 2022 | Health Equity Pilot Award, Hematology-Oncology Research Scholars Fund |
| 2018 | Match Day Speaker, Johns Hopkins School of Medicine |
| 2015 | Outstanding Screener Award at Charm City Clinic, Johns Hopkins School of Medicine |
| 2013 | Navin Narayan Award for Extraordinary Commitment to Public Service, Harvard College |
| 2013 | Carl and Lily Pforzheimer Public Service Fellowship, Harvard College |
| 2012 | Cordeiro Health Policy Fellowship, Harvard College |
| 2010 | David Rockefeller International Experience Award, Harvard College |
| 2009 | Edward J. Bloustein Distinguished Scholar |
| 2009 | Robert C. Byrd Honors Scholar |
| 2009 | Emory Award for Outstanding Service and Character Building |
Professional Memberships
Grant & Contract Support
| Date: | 2025 - 2030 |
| Title: | Increasing Uptake of Germline Genetic Testing among Prostate Cancer Patients in a Diverse Safety Net Hospital |
| Funding Source: | Cancer Prevention & Research Institute of Texas |
| Role: | PI |
| ID: | RP250475 |
| Date: | 2025 - 2026 |
| Title: | Facilitators and Barriers to Cancer Treatment Among Texas Medicare Beneficiaries |
| Funding Source: | Institutional Research Grant |
| Role: | Co-I |
| Date: | 2025 - 2027 |
| Title: | PEN: A Multi-Component Strategy Involving Patient Narratives, Education for Frontline Providers, and Navigation Services to Broaden Representation in Cancer Clinical Trials |
| Funding Source: | Robert A. Winn Excellence in Clinical Trials, Bristol Myers Squibb Foundation |
| Role: | PI |
| Date: | 2025 - 2026 |
| Title: | The Impact of HIV Infection and Prostate Cancer Treatment on Major Adverse Cardiovascular Events |
| Funding Source: | Texas Developmental Center for AIDS Research |
| Role: | PI |
| Date: | 2024 - 2025 |
| Title: | Delays in Treatment Initiation for Men with Prostate Cancer in Botswana |
| Funding Source: | American Society of Clinical Oncology (ASCO) Conquer Cancer |
| Role: | PI |
| Date: | 2022 - 2024 |
| Title: | Increasing Representation of Racial and Ethnic Minorities on Cancer Clinical Trials |
| Funding Source: | Hematology/Oncology Research Scholars Fund |
| Role: | PI |
Patient Reviews
CV information above last modified March 23, 2026